MolecularHealth

MolecularHealth is on the forefront of precision medicine, employing a pioneering approach called clinico-molecular informatics^(TM) to patient treatment. Our knowledge-driven^(TM) solutions translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into safer, more effective drug choices. For patients at risk of a serious adverse drug event, or for those awaiting their next course of cancer treatment, precision matters. MolecularHealth’s offerings range from a next generation drug safety assessment tool that analyzes the molecular basis of adverse events, to the first oncology decision support solution that transforms whole genome sequencing data into evidence-based treatment strategies.